Diagnostic and Therapeutic Trends in Alzheimer's Disease (Technical Insights)

Content

• Executive summary
  • Research scope and methodology
    • Research scope
    • Research methodology
  • Research highlights
    • Industry overview and key trends
    • Snapshot of noteworthy developments
• Technology primer
  • Alzheimer's disease (ad) overview
    • Ad--a century old pathology
    • Theories in ad--the role of plaques and tangles
    • Disease stages; symptoms; and statistics
  • Alzheimer's disease diagnosis and therapy overview
    • Diagnosis of ad
    • Therapy overview
• Technology intelligence in the ad space
  • Novel mechanism of action drugs--corporate advancements
    • A ‘food drug’ a day may keep alzheimer’s disease away
    • Protecting neurons by targeting cells’ powerhouses
    • Novel neuroprotective therapeutic agents may soon validate 'tau theory' in alzheimer's
    • Steroids mediated clearance of amyloid plaques in alzheimer’s
    • Improving memory by amplifying a novel receptor implicated in neurotransmission
    • A broad portfolio of novel drugs in the pipeline for alzheimer's
  • Ad therapeutics--academic research highlights
    • Study identifies molecule involved in beta-amyloid induced neuron death
    • Vaccine for alzheimer’s triggers a safe immune response and clears amyloid plaques in a mice study
  • Advances in ad diagnosis--corporate and academic efforts
    • Alzheimer’s diagnosis made simple and safe with a novel blood test
    • Advances in in vitro detection of the amyloid plaques in alzheimer’s
    • Computers to the rescue–a novel approach to early ad diagnosis
    • Imaging studies reveal a functional maker implicated in early alzheimer's disease
• Technology adoption factor analysis
  • Force-field analysis
    • The driving forces
    • The restraining forces and challenges
  • Strategic evaluation of the competitive environment
    • A strategic evaluation of ad medication space--swot analysis
    • Strategic assessment of competitive landscape and attractiveness of ad therapeutics sector--world
  • Current and futuretrends; industry roadmap; and strategic recommendations (analyst's perspectives)
    • Roadmap of diagnostic and therapeutic trends in ad sector
    • Strategic recommendations for existing symptomatic drugs
    • Strategic recommendations for disease modifying drugs
• Intellectual property (ip) scenario; key contacts
  • The ip scenario
    • Alzheimer's disease therapeutics--key patents
    • Alzheimer's disease diagnostics--key patents
  • Key contacts
    • Key corporate contacts
    • Key academic contacts
• Decision support database tables
  • Database tables
    • Total healthcare expenditure--world (2002 to 2012)
    • Pharmaceutical r&d expenditure--world (2002 to 2012)
    • Number of physicians--world (2002 to 2012)
    • Number of hospitals--world (2002 to 2012)
    • Number of nurses--world (2002 to 2012)